# Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

> **NCT03919994** · — · COMPLETED · sponsor: **Alkermes, Inc.** · enrollment: 338 (actual)

## Conditions studied

- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03919994
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-28
- **Primary completion:** 2023-01-04
- **Final completion:** 2023-01-04
- **Target enrollment:** 338 (ACTUAL)
- **Last updated:** 2023-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03919994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03919994, "Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03919994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*